Cresemba® (isavuconazonium) – Expanded indication
December 8, 2023 - Astellas announced the FDA approval of Cresemba (isavuconazonium), for the treatment of invasive aspergillosis (IA) and invasive mucormycosis (IM) in pediatric patients.
Download PDF
